Integrated approaches to management of hypertension: Promoting treatment acceptance

American Heart Journal

Volumn 138, Issue 3 II, 1999, Pages

  McInnes, G T ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADVERSE DRUG REACTION; ANTIHYPERTENSIVE THERAPY; DOCTOR PATIENT RELATION; HUMAN; HYPERTENSION; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

EID: 0032866110     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-8703(99)70318-2     Document Type: Review

References (20)

1. MacMahon S, Peto R, Cutler J, et al. Blood pressure stroke and coronary heart disease, I: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-74.
2. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull 1994;50:272-98.
3. Hansson L, Zanchetti A, Carruthers G, et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998;351:1755-62.
4. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-13.
5. Colhoun HM, Dong W, Poulter NR. Blood pressure screening, management and control in England: results from the health survey for England 1994. J Hypertens 1998;16:747-52.
6. Smith WCS, Lee AJ, Crombie IK, et al. Control of blood pressure in Scotland: the rule of halves. BMJ 1990;300:981-3.
7. Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men: a comparison of 6 antihypertensive agents with placebo. N Engl J Med 1993;328:914-21.
8. Neaton JD, Grimm RH, Prineas RJ, et al. Treatment of Mild Hypertension Study: final results. JAMA 1993;270:713-24.
9. Jones JK, Gorkin L, Lian JF, et al. Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. BMJ 1995;311:293-5.
10. Treatment of Mild Hypertension Research Group. The Treatment of Mild Hypertension Study: a randomised, placebo-controlled trial of a nutritional hygienic regimen along with various drug monotherapies. Arch Intern Med 1991;151:1413-23.
11. Black DM, Brand RJ, Greenlick M, et al, for the SHEP Pilot Research Group. Compliance to treatment for hypertension in elderly patients in the SHEP pilot study. J Gerontol 1987;42:552-7.
12. Curb DJ, Borhani NO, Blaszkowski TP, et al. Long term surveillance for adverse effects of antihypertensive drugs. JAMA 1985;253:3263-8.
13. Hansson L, Zanchetti A, for the HOT study group. The Hypertension Optimal Treatment (HOT) Study: 24-month data on blood pressure and tolerability. Blood Pressure 1997;6:313-7.
14. Jachuck SJ, Brierley H, Jachuck S, et al. The effect of hypertensive drugs on the quality of life. J R Coll Gen Pract 1982;32:103-5.
15. Croog SH, Levine S, Testa MA, et al. The effects of antihypertensive therapy on quality of life. N Engl J Med 1986;314:1657-64.
16. Herrick AL, Waller PC, Berkin KE, et al. Comparison of enalapril and atenolol in mild to moderate hypertension. Am J Med 1989;86:421-6.
17. Murphy J, Coster G. Issues in patient compliance. Drugs 1997;54: 797-800.
18. Fedder DO. Managing medication and compliance: physician-pharmacist-patient interaction. J Am Geriatr Soc 1982;30:S113-7.
19. Lip GYH, Beevers DG. A survey of the current practice of treating hypertension in primary care: the Rational Evaluation and Choice in Hypertension (REACH) Study. J Drug Dev Clin Pract 1996;8:161-9.
20. Urguhart J. The electronic medication event monitor: lessons for pharmacotherapy. Clin Pharmacokinet 1997;32:345-56.